Serb Galenika Says It Secures Certificate for Drug Sales in EU

Galenika AD, Serbia’s state-owned drugmaker, said it received a compliance certificate for non-sterile products that allows their sales in the European Union.

Painkillers, anti-coagulants, anti-anxiety and diabetes drugs, exported so far to non-EU neighbors and Russia, will also be offered in Asia and Africa, following the approval by regulator in EU member Slovenia, the company said in an e-mailed statement.

To contact the reporter on this story: Misha Savic in Belgrade at msavic2@bloomberg.net

To contact the editor responsible for this story: James M. Gomez at jagomez@bloomberg.net

Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.